HM30181

HM30181 is an inhibitor of P-glycoprotein (P-gp), also known as multidrug resistance protein 1 (MDR1; IC₅₀ = 0.63 nM).¹ It is selective for P-gp over breast cancer resistance protein (BCRP; IC₅₀ = 3,700 nM), as well as multidrug resistance-associated protein 1 (MRP1), MRP2, and MRP3 at 100 µM. It inhibits transepithelial basal-to-apical transport of paclitaxel in MDCK monolayers overexpressing P-gp (IC₅₀ = 35.4 nM). HM30181 inhibits tumor growth and induces tumor regression in an HT-29 mouse xenograft model when administered at doses of 10 and 20 mg/kg, respectively, in combination with paclitaxel (Item No. 10461).

WARNING This product is not for human or veterinary use.

1. Kwak, J.-O., Lee, S.H., Lee, G.S., et al. Selective inhibition of MDR1 (ABCB1) by HM30181 increases oral bioavailability and therapeutic efficacy of paclitaxel. Eur. J. Pharmacol. 627(1-3), 92-98 (2009).